Illinois CancerCare-Peru is a clinical research site located in Peru, Illinois, United States 61354.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Illinois CancerCare-Peru has participated in 436 clinical trials with 248 currently active.
Therapeutic areas: Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Peru
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Illinois CancerCare-Peru has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Illinois CancerCare-Peru has 436 clinical trials on record, with 248 currently active. Their work covers Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome.
Illinois CancerCare-Peru has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.